Medicinova (MNOV) Other Non-Current Liabilities (2018 - 2025)
Medicinova's (MNOV) quarterly Other Non-Current Liabilities came in at $17129.0 in Q4 2025, down 91.9% year-on-year from $211460.0 in Q4 2024, and down 76.98% on a QoQ basis from $74399.0 in Q3 2025.
Medicinova (MNOV) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends
Medicinova (MNOV) has 8 years of Other Non-Current Liabilities data on file, last reported at $17129.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities fell 91.9% year-over-year to $17129.0 in Q4 2025; TTM through Dec 2025 was $17129.0, a 91.9% decrease from a year earlier, with the FY2025 full-year figure at $17129.0, down 91.9% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $17129.0, down from $74399.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for MNOV reached as high as $737716.0 in Q3 2021 and fell as low as $2211.0 in Q1 2021.
- Historically, Other Non-Current Liabilities has averaged $359947.2 across 5 years, with a median of $380922.5 in 2023.
- Across the five-year window, Other Non-Current Liabilities sank 98.27% in 2021 and soared 28523.65% in 2022, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $694674.0 in 2021, then decreased by 24.62% to $523619.0 in 2022, then slipped by 21.57% to $410660.0 in 2023, then sank by 48.51% to $211460.0 in 2024, then sank by 91.9% to $17129.0 in 2025.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $17129.0 in Q4 2025, $74399.0 in Q3 2025, and $117038.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,129.00 |
| Sep 30, 2025 | 74,399.00 |
| Jun 30, 2025 | 117,038.00 |
| Mar 31, 2025 | 165,198.00 |
| Dec 31, 2024 | 211,460.00 |
| Sep 30, 2024 | 255,150.00 |
| Jun 30, 2024 | 302,483.00 |
| Mar 31, 2024 | 351,185.00 |
| Dec 31, 2023 | 410,660.00 |
| Sep 30, 2023 | 463,838.00 |
| Jun 30, 2023 | 519,685.00 |
| Mar 31, 2023 | 489,379.00 |
| Dec 31, 2022 | 523,619.00 |
| Sep 30, 2022 | 555,840.00 |
| Jun 30, 2022 | 587,404.00 |
| Mar 31, 2022 | 632,869.00 |
| Dec 31, 2021 | 694,674.00 |
| Sep 30, 2021 | 737,716.00 |
| Jun 30, 2021 | 87,007.00 |
| Mar 31, 2021 | 2,211.00 |